Published in Eur J Clin Microbiol Infect Dis on April 03, 2012
Primary meningococcal polyarthritis in an adult woman. Case Rep Med (2015) 0.77
Acute polyarthritis in a young patient caused by meningococcal and parvovirus B19 infections: a case report and review of the literature. J Med Case Rep (2016) 0.75
A pain in the joints. BMJ Case Rep (2015) 0.75
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis. Hum Vaccin Immunother (2016) 0.75
Does Dexamethasone Helps in Meningococcal Sepsis? Med Arch (2017) 0.75
Arthritis secondary to meningococcal disease: A case series of 7 patients. Medicine (Baltimore) (2017) 0.75
Arthritis in disease due to Neisseria meningitidis. Rev Infect Dis (1981) 1.86
Clinical features and outcome of pediatric Neisseria meningitidis serogroup W135 infection: a report of 5 cases. Clin Infect Dis (2004) 1.69
The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis (2003) 1.41
Immune complex associated complications in the subacute phase of meningococcal disease: incidence and literature review. Arch Dis Child (2003) 1.19
Clinical features of meningococcal arthritis: a report of four cases. Ann Rheum Dis (1985) 1.16
Arthritis in adults with community-acquired bacterial meningitis: a prospective cohort study. BMC Infect Dis (2006) 1.04
Primary meningococcal arthritis. Pediatr Infect Dis J (1997) 0.97
Meningococcemia presenting as septic arthritis, pericarditis, and tenosynovitis. Arthritis Rheum (1985) 0.87
Meningococcal-associated arthritis: infection versus immune-mediated. Intern Med J (2008) 0.86
Steroid-responsive vasculitis and arthritis in meningococcal septicaemia. Postgrad Med J (1980) 0.85
Advances in the management of septic arthritis. Rheum Dis Clin North Am (2003) 0.82
Four days of penicillin therapy for meningococcal meningitis. Arch Intern Med (1986) 0.80
Tenosynovitis in meningococcemia. Arthritis Rheum (1987) 0.80
An unusual cause of acute polyarticular arthritis. Clin Pediatr (Phila) (2008) 0.77
Serous flexor tenosynovitis as an associated finding in meningococcal septic polyarthritis. Am J Orthop (Belle Mead NJ) (2002) 0.76
Incidence and outcome of arthritis in meningococcal disease. J Indian Med Assoc (2009) 0.76
Immune complex reaction after successful treatment of meningococcal disease: an excellent response to IVIG. Rheumatol Int (2010) 0.75
Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med (1995) 4.38
Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis (1992) 3.37
Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol (2000) 3.23
Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med (1987) 2.78
Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother (1998) 2.40
Isolation of Neisseria meningitidis strains with increase of penicillin minimal inhibitory concentrations. Epidemiol Infect (1987) 2.34
Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet (1999) 2.30
Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med (1988) 2.24
Adult onset Still's disease: review of 41 cases. Clin Exp Rheumatol (2011) 2.15
Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother (1991) 2.13
High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy. Eur J Clin Invest (2008) 2.05
Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: a multi-national study. Clin Microbiol Infect (2014) 2.02
Lack of response to teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw. Osteoporos Int (2012) 2.01
Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J Antimicrob Chemother (1998) 2.00
Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia. Eur Respir J (2002) 2.00
Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1994) 1.85
Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections. Antimicrob Agents Chemother (1995) 1.78
Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin Infect Dis (1996) 1.68
Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis (1995) 1.67
Streptococcal meningitis in adult patients: current epidemiology and clinical spectrum. Clin Infect Dis (1999) 1.66
Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Antimicrob Agents Chemother (1985) 1.63
Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med (1996) 1.61
Risk factors for nosocomial Legionella pneumophila pneumonia. Am J Respir Crit Care Med (1994) 1.61
Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. Clin Microbiol Infect (2014) 1.61
Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect (1997) 1.58
Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Ann Intern Med (1992) 1.58
Infected hip hemiarthroplasties and total hip arthroplasties: Differential findings and prognosis. J Infect (2013) 1.49
[Grade of consistency existing in the grade of hepatic fibrosis calculated with the APRI and FORNS biochemistry indexes and transient elastography (Fibroscan in patients coinfected with HIV-HCV]. Rev Clin Esp (2010) 1.44
[Provocation test using metaraminol in a case of familial Mediterranean fever]. Rev Clin Esp (1990) 1.39
[Pulmonary hemorrhage and anti-phospholipid syndrome]. Rev Clin Esp (2004) 1.38
Complement is not activated in AB0-haemolytic disease of the newborn: two exceptions. Vox Sang (1991) 1.38
Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin Microbiol Infect (2005) 1.36
Specific antibodies detected during relapse of human brucellosis. J Infect Dis (1988) 1.33
In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis. J Antimicrob Chemother (1986) 1.32
Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV. BMJ (1990) 1.30
Gram-negative bacillary cellulitis in patients with hepatic cirrhosis. Eur J Clin Microbiol Infect Dis (1994) 1.27
Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii. Antimicrob Agents Chemother (2002) 1.26
Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality. J Hosp Infect (2008) 1.23
Pneumococcal peritonitis in adult patients: report of 64 cases with special reference to emergence of antibiotic resistance. Arch Intern Med (2001) 1.19
Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis (2000) 1.18
Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology (Oxford) (1999) 1.17
Usefulness of PCR and antigen latex agglutination test with samples obtained by transthoracic needle aspiration for diagnosis of pneumococcal pneumonia. J Clin Microbiol (1999) 1.17
Nosocomial spread of Pseudomonas aeruginosa producing the metallo-beta-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications. Clin Microbiol Infect (2007) 1.16
Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients. Clin Microbiol Infect (2006) 1.16
Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis. Antimicrob Agents Chemother (1986) 1.16
Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology (Oxford) (2005) 1.15
Comparative trial of co-trimoxazole versus tetracycline-streptomycin in treating human brucellosis. J Infect Dis (1985) 1.14
Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients. Antimicrob Agents Chemother (2007) 1.14
Salivary testosterone in postmenopausal women with rheumatoid arthritis. J Rheumatol (1998) 1.13
Protected bronchoalveolar lavage in the diagnosis of ventilator-associated pneumonia. Eur Respir J (1996) 1.13
Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother (2006) 1.13
Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. J Hosp Infect (1997) 1.12
Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2010) 1.09
Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever. Antimicrob Agents Chemother (1989) 1.09
Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients. Eur J Clin Microbiol Infect Dis (1997) 1.08
Brucellar spondylitis: a detailed analysis based on current findings. Rev Infect Dis (1985) 1.07
Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2009) 1.07
Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrob Agents Chemother (1995) 1.07
Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality. Eur J Clin Microbiol Infect Dis (2013) 1.07
Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J (2008) 1.06
Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin Microbiol Infect (2009) 1.05
Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. A matched case-control study. Arch Intern Med (1993) 1.04
Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 betta-lactamase. J Clin Microbiol (2009) 1.04
Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect (2011) 1.03
Listeria monocytogenes meningoencephalitis in adults: analysis of factors related to unfavourable outcome. Infection (2014) 1.03
An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase. J Hosp Infect (2001) 1.03
Short-term effect of the application of selective decontamination of the digestive tract on different body site reservoir ICU patients colonized by multi-resistant Acinetobacter baumannii. J Antimicrob Chemother (2002) 1.01
Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy. Clin Microbiol Infect (2010) 0.98
Epididymoorchitis due to Brucella mellitensis: a retrospective study of 59 patients. Clin Infect Dis (2001) 0.98
Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitals. Antimicrob Agents Chemother (2004) 0.97
Etiological agent and primary source of infection in 42 cases of focal intracranial suppuration. J Clin Microbiol (1986) 0.96
Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital. J Hosp Infect (2007) 0.96
Nutritional status in patients with rheumatoid arthritis. Joint Bone Spine (2001) 0.96
A single daily dose of ceftriaxone for bacterial meningitis in adults: experience with 84 patients and review of the literature. Clin Infect Dis (1995) 0.96
Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis (1995) 0.95
Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii. J Antimicrob Chemother (1999) 0.94
Brucellar sacroiliitis: findings in 63 episodes and current relevance. Clin Infect Dis (1993) 0.94
Fosfomycin-daptomycin and other fosfomycin combinations as alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2012) 0.94
Secondary serological response of patients with chronic hepatosplenic suppurative brucellosis. Clin Vaccine Immunol (2006) 0.93
Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain. Clin Microbiol Infect (2008) 0.93
Staphylococcus aureus nasal carriage in patients on haemodialysis: role of cutaneous colonization. J Hosp Infect (2004) 0.93
Thermal and 13C-NMR study of the dynamic structure of 1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine and 1-oleyl-2-palmitoyl-sn-glycero-3-phosphocholine in aqueous dispersions. Biochim Biophys Acta (1982) 0.93